Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
33,978,355
-
Share change
-
+8,872,148
-
Total reported value
-
$84,901,007
-
Put/Call ratio
-
37%
-
Price per share
-
$2.50
-
Number of holders
-
86
-
Value change
-
+$20,428,763
-
Number of buys
-
59
-
Number of sells
-
26
Institutional Holders of GALENA BIOPHARMA INC - COM (GALE) as of Q1 2014
As of 31 Mar 2014 GALENA BIOPHARMA INC - COM (GALE) had 86 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 33,978,355 shares of stock of the company.
Largest 10 holders included State Street Corp, Consonance Capital Management LP, BlackRock Institutional Trust Company, N.A., BlackRock Fund Advisors, VANGUARD GROUP INC, NORTHERN TRUST CORP, TIAA CREF INVESTMENT MANAGEMENT LLC, SABBY MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, and Bank of New York Mellon Corp.
This table shows 86 institutional shareholders of the security as of 31 Mar 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.